MISaa value proposition
The Problem
The Solution
The Solution
- Tacrolimus (TAC) is an essential immunosuppressive drug for solid-organ and tissue transplant patients.
- Frequent patient monitoring is critical
- LC-MS/MS is time consuming, painful and contributes to patient non-compliance.
The Solution
The Solution
The Solution
- The MISAA eLFA has been validated against LC/MS-MS with 56 kidney transplant recipients to date
- Strong interrelationship – Pearson correlation r = 0.90
- Good agreement – Bland-Altman analysis mean bias = 0.7 ng/mL at 95% limit of agreement.